Hi Dr X, A colleague sent me your latest paper after seeing your presentation at AACR. Dr Piro Lito (MSKCC) used our technology to map resistance mechanisms in KRAS G12Ci treated PDX models. He’s able to test with 100% certainty how this patient’s tumors are evolving in response to specific therapies I’ve meetings at XXXXXXX today and tomorrow. Would it make sense for me to stop by and see if our technology could be helpful in the next phase of your trial? Thanks Ohi
That looks like a strong email to me! I wish my product was so specific!
